Six deliverables. Every engagement.
From raw claims data to a board-ready executive summary, each deliverable is purpose-built to drive a specific decision — not to fill a binder.
Category-level spend breakdown, PMPM trending, utilization benchmarks, and high-cost claimant identification — with actionable flags for immediate attention.
A sequenced, prioritized plan across funding, vendors, clinical programs, and cost containment — built around your data, not a template.
Side-by-side modeling of your current trajectory versus proposed interventions — with projected savings, break-even timelines, and sensitivity ranges.
Top drug spend ranking, specialty vs. generic ratio, biosimilar opportunity sizing, and PBM contract performance vs. market — flagging where you're overpaying.
Current vs. recommended stop-loss design across specific deductible, aggregate factor, contract terms, and laser exposure — with market placement recommendations.
A clean, decision-focused executive brief distilling all findings into key risk flags, financial opportunities, and a prioritized action plan — formatted for C-suite and board presentation.